The AimwellBio Observer network.
Credentialed biopharma professionals, researchers, and practitioners who have verified institutional access and opted into public listing. Observer access is free.
The directory is not yet public. To connect with verified Observers directly, reach us at:
Observer is the front door. Here’s the ladder past it.
Observer access is free and verified — 5 source-traced verdicts, AIMN:ATLAS read access, and a public profile are active today. Your signal feed, watchlist, and dossiers activate during onboarding as the engine ships. Each seat above raises what you can do.
Command tier is sales-assisted. Request Command access →
The areas with a curated corpus behind them.
Counts and last-compiled dates read straight from the dataset on disk — sources are PubMed, ClinicalTrials.gov, FDA, and SEC EDGAR. A scheduled-refresh, curated corpus, compiled on a schedule.
The serious people are organizing here first.
A verified network is only as strong as who is in it. If a colleague meets the credentialing bar, send them the door — no points, no referral bonus, just a stronger room. That is the only incentive we would stand behind.